<?xml version="1.0" encoding="UTF-8"?>
<ref id="B249-antioxidants-09-01191">
 <label>249.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Jiang</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Song</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Song</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>New application of the commercial sweetener rebaudioside a as a hepatoprotective candidate: Induction of the Nrf2 signaling pathway</article-title>
  <source>Eur. J. Pharmacol.</source>
  <year>2018</year>
  <volume>822</volume>
  <fpage>128</fpage>
  <lpage>137</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ejphar.2018.01.020</pub-id>
  <pub-id pub-id-type="pmid">29355553</pub-id>
 </element-citation>
</ref>
